Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, ...

The TV personality, 71 - who once topped the scales at 237lbs in 1992 - finally reached her 160lb goal weight in 2023 after ...

Weight-loss drugs are this decade’s blockbuster medicines. Drugs like Ozempic, Wegovy, and Mounjaro help people with diabetes ...

Paramedic Alison Tarrant had struggled with binge-eating and her weight after having children and, in 2019 after reaching 16 ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Dental claims have also contributed to the rising costs. Claims through May 2025 are at “99% of the dental plan premiums,” which could normally warrant a rate increase of more than 15%. However, a ...

The Centers for Disease Control and Prevention recommends at least 150 minutes of moderate intensity exercise per week – like ...

SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Losing weight and keeping it off is a struggle for many people. Diet, exercise, health, family history of health conditions, ...

In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs ...